Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,312 | 92 | 99.0% |
| Consulting Fee | $64.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,098 | 43 | $0 (2024) |
| Abbott Laboratories | $721.45 | 12 | $0 (2024) |
| Nevro Corp. | $600.48 | 9 | $0 (2023) |
| Foundation Fusion Solutions, LLC | $492.62 | 3 | $0 (2020) |
| Medtronic USA, Inc. | $405.11 | 5 | $0 (2020) |
| Medtronic, Inc. | $321.99 | 3 | $0 (2023) |
| Stimwave Technologies Incorporated | $172.79 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $124.78 | 1 | $0 (2021) |
| ABBVIE INC. | $120.67 | 5 | $0 (2024) |
| Relievant Medsystems, Inc. | $112.87 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,125 | 13 | Boston Scientific Corporation ($867.30) |
| 2023 | $960.83 | 15 | Boston Scientific Corporation ($508.71) |
| 2022 | $642.59 | 8 | Boston Scientific Corporation ($229.64) |
| 2021 | $769.25 | 11 | Nevro Corp. ($318.06) |
| 2020 | $1,910 | 26 | Boston Scientific Corporation ($808.19) |
| 2019 | $642.00 | 14 | Boston Scientific Corporation ($316.80) |
| 2018 | $118.34 | 4 | Boston Scientific Corporation ($56.11) |
| 2017 | $207.97 | 2 | BOSTON SCIENTIFIC CORPORATION ($143.97) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $128.60 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/27/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $154.78 | General |
| Category: General - Pain Management_NMD | ||||||
| 07/27/2024 | Boston Scientific Corporation | CoverEdge 32 (Device) | Food and Beverage | In-kind items and services | $160.68 | General |
| Category: CoverEdge_NMD | ||||||
| 06/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $121.76 | General |
| Category: Neuromodulation | ||||||
| 06/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Neuromodulation | ||||||
| 06/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $118.56 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Neuromodulation | ||||||
| 04/04/2024 | Boston Scientific Corporation | Click (Device) | Food and Beverage | In-kind items and services | $152.52 | General |
| Category: Click_NMD | ||||||
| 02/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $152.16 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 01/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Neuromodulation | ||||||
| 11/04/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 10/13/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Neuromodulation | ||||||
| 09/12/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $119.09 | General |
| Category: Neuromodulation | ||||||
| 08/20/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/16/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $100.05 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 06/21/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $90.20 | General |
| Category: Neuromodulation | ||||||
| 06/09/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 06/07/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $53.57 | General |
| Category: Neuromodulation | ||||||
| 05/26/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $34.84 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/05/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Clinical Trial Product_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 134 | 154 | $94,270 | $11,454 |
| 2022 | 3 | 193 | 299 | $167,618 | $20,559 |
| 2021 | 4 | 282 | 374 | $210,024 | $29,500 |
| 2020 | 7 | 137 | 171 | $229,529 | $15,855 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 49 | $28,665 | $4,789 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 65 | $34,125 | $4,284 | 12.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 38 | 40 | $31,480 | $2,381 | 7.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 174 | $85,080 | $11,535 | 13.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 64 | 83 | $59,345 | $4,649 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 42 | $23,193 | $4,375 | 18.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 120 | 173 | $75,154 | $12,163 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 105 | $52,003 | $10,604 | 20.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 73 | 83 | $55,380 | $5,109 | 9.2% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Facility | 2021 | 12 | 13 | $27,487 | $1,625 | 5.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Facility | 2020 | 15 | 25 | $74,075 | $4,743 | 6.4% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Facility | 2020 | 23 | 27 | $55,377 | $2,917 | 5.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 44 | $18,550 | $2,674 | 14.4% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | Facility | 2020 | 16 | 19 | $30,799 | $1,916 | 6.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 19 | $9,180 | $1,614 | 17.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves with imaging guidance | Facility | 2020 | 15 | 26 | $34,398 | $1,308 | 3.8% |
| 80307 | Testing for presence of drug | Office | 2020 | 11 | 11 | $7,150 | $683.54 | 9.6% |
About Dr. Luis Velazquez, M.D
Dr. Luis Velazquez, M.D is a Anesthesiology healthcare provider based in N Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1194975623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Velazquez, M.D has received a total of $6,376 in payments from pharmaceutical and medical device companies, with $1,125 received in 2024. These payments were reported across 93 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($6,312).
As a Medicare-enrolled provider, Velazquez has provided services to 746 Medicare beneficiaries, totaling 998 services with total Medicare billing of $77,368. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Pain Medicine
- Location N Las Vegas, NV
- Active Since 09/20/2008
- Last Updated 03/26/2019
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1194975623
Products in Payments
- GENERAL - PAIN MANAGEMENT (Device) $667.77
- Omnia (Device) $507.22
- PROCLAIM (Device) $379.41
- GENERAL PAIN MANAGEMENT (Device) $280.11
- INTELLIS ADAPTIVESTIM (Device) $234.42
- MYSTIM (Device) $231.29
- SPECTRA WAVEWRITER (Device) $200.84
- GENERAL PAIN MANAGEMENT (Device) $167.69
- General - Pain Management (Device) $167.28
- CoverEdge 32 (Device) $160.68
- Click (Device) $152.52
- Penta SCS Leads (Device) $145.07
- KYPHON Balloon Kyphoplasty (Device) $144.71
- SPECTRA SYSTEM (Device) $143.97
- Octrode SCS Leads (Device) $143.40
- FARXIGA (Drug) $124.78
- Intracept (Device) $112.87
- QULIPTA (Drug) $89.87
- VANTA ADAPTIVESTIM (Device) $87.57
- WaveWriter Alpha Prime 16 (Device) $69.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.